Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mialhe, A.
Right arrow Articles by Job, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mialhe, A.
Right arrow Articles by Job, D.
[Cancer Research 61, 5024-5027, July 1, 2001]
© 2001 American Association for Cancer Research


Clinical Investigations

Tubulin Detyrosination Is a Frequent Occurrence in Breast Cancers of Poor Prognosis1

Agnes Mialhe2, Laurence Lafanechèere2, Isabelle Treilleux, Nadine Peloux, Charles Dumontet, Alain Brémond, Meng-Hong Panh, Raoul Payan, Jürgen Wehland, Robert-Louis Margolis and Didier Job3

Laboratoire du Cytosquelette, Institut National de la Santé et de la Recherche Médicale (INSERM) U366, Département de Biologie Molèeculaire et Structurale, Commissariat á l’Energie Atomique, 38054 Grenoble Cedex 9, France [A. M., L. L., D. J.]; Département d’Anatomie et de Cytologie Pathologiques, Centre Léon Bérard, 69373 Lyon, France [I. T., N. P., C. D., A. B.]; Clinique Belledonne, 38400 Saint Martin d’Hèeres, France [M. H. P., R. P.]; Gesellschaft für Biotechnologische Forschung mbH, 38092 Braunschweig, Germany [J. W.]; and Institut de Biologie Structurale J. P. Ebel (Commissariat á l’Energie Atomique-Centre National de la Recherche Scientifique), 38027 Grenoble Cedex 1, France [R. L. M.]

Tubulin, the dimeric subunit of microtubules, is a major cell protein that is centrally involved in cell division. Tubulin is subject to specific enzymatic posttranslational modifications including cyclic tyrosine removal and addition at the COOH terminus of the {alpha}-subunit. Tubulin is normally extensively tyrosinated in cycling cells. However, we have previously shown that detyrosinated tubulin accumulates in cancer cells during tumor progression in nude mice. Tubulin detyrosination, resulting from suppression of tubulin tyrosine ligase and the resulting unbalanced activity of tubulin-carboxypeptidase, apparently represents a strong selective advantage for cancer cells. We have now analyzed the occurrence and significance of tubulin detyrosination in human breast tumors. We studied a total of 134 breast cancer tumors from patients with or without known complications over a follow-up period of 31 ± 10 months. The mean age of the patients at the time of diagnosis was 57 years. For each patient, detailed data concerning the histology and extension of the tumor were available. Tumor cells containing detyrosinated tubulin were visualized by immunohistochemical staining of paraffin-embedded tissue sections.

Cancer cells with detyrosinated tubulin were observed in 53% of the tumors and were predominant in 19.4% of the tumors. Tubulin detyrosination correlated to a high degree of significance (P < 0.001) with a high Scarf-Bloom-Richardson (SBR) grade, a known marker of tumor aggressiveness. Among SBR grade 1 tumors, 3.8% were strongly positive for tubulin detyrosination compared with 65.4% of the SBR grade 3 tumors. The SBR component showing the strongest correlation with tubulin detyrosination was the mitotic score. In the entire patient population, neither the SBR grade nor the detyrosination index had significant prognostic value (P = 0.11, P = 0.27, respectively), whereas a combined index was significantly correlated with the clinical outcome (P = 0.02). A preliminary subgroup analysis indicated that tubulin detyrosination may define high- and low- risk groups in breast cancer tumors with an SBR grade of 2. Our study shows that tubulin detyrosination is a frequent occurrence in breast cancer, easy to detect, and linked to tumor aggressiveness.




This article has been cited by other articles:


Home page
JCBHome page
L. Peris, M. Wagenbach, L. Lafanechere, J. Brocard, A. T. Moore, F. Kozielski, D. Job, L. Wordeman, and A. Andrieux
Motor-dependent microtubule disassembly driven by tubulin tyrosination
J. Cell Biol., June 29, 2009; 185(7): 1159 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Zekert and R. Fischer
The Aspergillus nidulans Kinesin-3 UncA Motor Moves Vesicles along a Subpopulation of Microtubules
Mol. Biol. Cell, January 1, 2009; 20(2): 673 - 684.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Whipple, E. M. Balzer, E. H. Cho, M. A. Matrone, J. R. Yoon, and S. S. Martin
Vimentin Filaments Support Extension of Tubulin-Based Microtentacles in Detached Breast Tumor Cells
Cancer Res., July 15, 2008; 68(14): 5678 - 5688.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Barco, L. B. Hunt, A. L. Frump, C. B. Garcia, A. Benesh, R. L. Caldwell, and J. E. Eid
The Synovial Sarcoma SYT-SSX2 Oncogene Remodels the Cytoskeleton through Activation of the Ephrin Pathway
Mol. Biol. Cell, October 1, 2007; 18(10): 4003 - 4012.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Fonrose, F. Ausseil, E. Soleilhac, V. Masson, B. David, I. Pouny, J.-C. Cintrat, B. Rousseau, C. Barette, G. Massiot, et al.
Parthenolide Inhibits Tubulin Carboxypeptidase Activity
Cancer Res., April 1, 2007; 67(7): 3371 - 3378.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
F. Vandermoere, I. E. Yazidi-Belkoura, Y. Demont, C. Slomianny, J. Antol, J. Lemoine, and H. Hondermarck
Proteomics Exploration Reveals That Actin Is a Signaling Target of the Kinase Akt
Mol. Cell. Proteomics, January 1, 2007; 6(1): 114 - 124.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Peris, M. Thery, J. Faure, Y. Saoudi, L. Lafanechere, J. K. Chilton, P. Gordon-Weeks, N. Galjart, M. Bornens, L. Wordeman, et al.
Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends
J. Cell Biol., September 11, 2006; 174(6): 839 - 849.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Erck, L. Peris, A. Andrieux, C. Meissirel, A. D. Gruber, M. Vernet, A. Schweitzer, Y. Saoudi, H. Pointu, C. Bosc, et al.
A vital role of tubulin-tyrosine-ligase for neuronal organization
PNAS, May 31, 2005; 102(22): 7853 - 7858.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. A. Low, S. B. Wedam, J. J. Lee, A. W. Berman, A. Brufsky, S. X. Yang, M. S. Poruchynsky, S. M. Steinberg, N. Mannan, T. Fojo, et al.
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer
J. Clin. Oncol., April 20, 2005; 23(12): 2726 - 2734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-O. Yoon, S. Shin, and A. M. Mercurio
Hypoxia Stimulates Carcinoma Invasion by Stabilizing Microtubules and Promoting the Rab11 Trafficking of the {alpha}6{beta}4 Integrin
Cancer Res., April 1, 2005; 65(7): 2761 - 2769.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. D. Unwin, D. W. Sternberg, Y. Lu, A. Pierce, D. G. Gilliland, and A. D. Whetton
Global Effects of BCR/ABL and TEL/PDGFR{beta} Expression on the Proteome and Phosphoproteome: IDENTIFICATION OF THE RHO PATHWAY AS A TARGET OF BCR/ABL
J. Biol. Chem., February 25, 2005; 280(8): 6316 - 6326.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Bloom
Microtubule composition: Cryptography of dynamic polymers
PNAS, May 4, 2004; 101(18): 6839 - 6840.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. C. Badin-Larcon, C. Boscheron, J. M. Soleilhac, M. Piel, C. Mann, E. Denarier, A. Fourest-Lieuvin, L. Lafanechere, M. Bornens, and D. Job
From the Cover: Suppression of nuclear oscillations in Saccharomyces cerevisiae expressing Glu tubulin
PNAS, April 13, 2004; 101(15): 5577 - 5582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.